Dietary Fat Intake: Promotion of Disease in Carotid Artery Disease: Lipid Lowering Versus Side Effects of Statins
作者： Rakesh Sharma , Ram B. Singh , Robert J. Moffatt , Jose Katz
DOI: 10.1007/978-1-60327-571-2_10
关键词:
摘要: Carotid artery disease is the outcome of elevated blood lipids and “cardiovascular incapability” to detect initial stages atherosclerosis such as integration endothelial dysfunction, smooth muscle cell metabolic abnormality carotid wall. Initially, dyslipidemia developed cause due lipid disorder. Later it leads common in atherosclerosis, systemic inflammatory disorders, vascular atrophy.
springer.com
sci-hub.st 参考文章(197)
Birgül Vanizor Kural, Cihan Örem, Hüseyin A Uydu, Ahmet Alver, Asm Örem, None, The effects of lipid-lowering therapy on paraoxonase activities and their relationships with the oxidant-antioxidant system in patients with dyslipidemia. Coronary Artery Disease. ,vol. 15, pp. 277- 283 ,(2004) , 10.1097/01.MCA.0000135221.32523.A1
Satoru Niwa, Tetsuya Totsuka, Shigehiro Hayashi, Inhibitory effect of fluvastatin, an HMG-CoA reductase inhibitor, on the expression of adhesion molecules on human monocyte cell line International Journal of Immunopharmacology. ,vol. 18, pp. 669- 675 ,(1996) , 10.1016/S0192-0561(96)00068-9
Carol S. Stilley, Susan Sereika, Matthew F. Muldoon, Christopher M. Ryan, Jacqueline Dunbar-Jacob, Psychological and cognitive function: predictors of adherence with cholesterol lowering treatment. Annals of Behavioral Medicine. ,vol. 27, pp. 117- 124 ,(2004) , 10.1207/S15324796ABM2702_6
Donald G. Vidt, Michael D. Cressman, Susan Harris, John S. Pears, Howard G. Hutchinson, Rosuvastatin-induced arrest in progression of renal disease. The Cardiology. ,vol. 102, pp. 52- 60 ,(2004) , 10.1159/000077704
Kuniharu SUZUMURA, Mikiko YASUHARA, Keiko TANAKA, Akio ODAWARA, Hiroshi NARITA, Toshikazu SUZUKI, An in Vitro Study of the Hydroxyl Radical Scavengin Property of Fluvastatin, and HMG-CoA Reductase Inhibitor Chemical & Pharmaceutical Bulletin. ,vol. 47, pp. 1010- 1012 ,(1999) , 10.1248/CPB.47.1010
José Martı́nez-González, José Alfón, Marı́a Berrozpe, Lina Badimon, HMG-CoA reductase inhibitors reduce vascular monocyte chemotactic protein-1 expression in early lesions from hypercholesterolemic swine independently of their effect on plasma cholesterol levels Atherosclerosis. ,vol. 159, pp. 27- 33 ,(2001) , 10.1016/S0021-9150(01)00469-5
Kensuke Egashira, Tetsuzi Inou, Yoshitaka Hirooka, Akira Yamada, Yoshitoshi Urabe, Akira Takeshita, None, Evidence of Impaired Endothelium-Dependent Coronary Vasodilatation in Patients with Angina Pectoris and Normal Coronary Angiograms The New England Journal of Medicine. ,vol. 328, pp. 1659- 1664 ,(1993) , 10.1056/NEJM199306103282302
Bernard Noël, Renato G. Panizzon, Lupus-Like Syndrome Associated with Statin Therapy Dermatology. ,vol. 208, pp. 276- 277 ,(2004) , 10.1159/000077320
Paul Lijnen, Hilde Celis, Robert Fagard, Jan Staessen, Antoon Amery, Influence of cholesterol lowering on plasma membrane lipids and cationic transport systems. Journal of Hypertension. ,vol. 12, pp. 59- 64 ,(1994) , 10.1097/00004872-199401000-00009
Robin J. Edison, Maximilian Muenke, Central Nervous System and Limb Anomalies in Case Reports of First-Trimester Statin Exposure New England Journal of Medicine. ,vol. 350, pp. 1579- 1582 ,(2004) , 10.1056/NEJM200404083501524